欧盟EMA药品数据库-欧盟集中审批药品
（European Medicines Agency Authorisation of Medicines DataBase）
请输入需要查询的英文药品名称，通用名称，活性成分，产品号
*Search by Medicine name,INN,Active substance,Product number.
高级搜索
数据记录共 2679 条，共 134 页，当前第 71 页
可点击列名称排序
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Vantavo (previously Alendronate sodium and colecalciferol, MSD) Human alendronic acid;colecalciferol alendronic acid;colecalciferol EMEA/H/C/001180 Organon N.V. 2009/10/16 Authorised
Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Human clopidogrel clopidogrel besilate EMEA/H/C/001189 Viatris Limited 2009/10/16 Authorised
Pandemic Influenza Vaccine H5N1 Baxter AG Human pandemic influenza vaccine (H5N1) (whole virion, inactivated, prepared in cell culture) influenza vaccine (whole virion, inactivated) containing antigen of: A/Vietnam/1203/2004 (H5N1) EMEA/H/C/001200 Resilience Biomanufacturing Ireland Limited 2009/10/16 Withdrawn
Exforge HCT Human amlodipine besilate;valsartan;hydrochlorothiazide valsartan;hydrochlorothiazide;amlodipine besilate EMEA/H/C/001068 Novartis Europharm Limited 2009/10/15 Authorised
Imprida HCT Human amlodipine;valsartan;hydrochlorothiazide amlodipine;valsartan;hydrochlorothiazide EMEA/H/C/001161 Novartis Europharm Ltd. 2009/10/15 Lapsed
Resolor Human prucalopride prucalopride succinate EMEA/H/C/001012 Takeda Pharmaceuticals International AG Ireland 2009/10/14 Authorised
Enyglid Human repaglinide repaglinide EMEA/H/C/001065 Krka, d.d., Novo mesto 2009/10/13 Authorised
Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) Human pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14) EMEA/H/C/001206 GlaxoSmithKline Biologicals S.A. 2009/10/10 Authorised
ChondroCelect Human characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins EMEA/H/C/000878 TiGenix N.V. 2009/10/05 Withdrawn
Simponi Human golimumab golimumab EMEA/H/C/000992 Janssen Cilag International NV 2009/10/01 Authorised
Cimzia Human certolizumab pegol certolizumab pegol EMEA/H/C/001037 UCB Pharma 2009/10/01 Authorised
Onglyza Human saxagliptin saxagliptin EMEA/H/C/001039 AstraZeneca AB 2009/09/30 Authorised
Zyllt Human clopidogrel clopidogrel (as hydrogen sulfate) EMEA/H/C/001058 Krka, d.d., Novo mesto 2009/09/28 Authorised
Clopidogrel Krka Human clopidogrel clopidogrel (as hydrochloride) EMEA/H/C/001056 Krka, d.d., Novo mesto 2009/09/23 Authorised
Clopidogrel TAD Human clopidogrel clopidogrel (as hydrochloride) EMEA/H/C/001136 Tad Pharma GmbH 2009/09/23 Authorised
Clopidogrel Qualimed Human clopidogrel clopidogrel (as hydrochloride) EMEA/H/C/001135 Qualimed 2009/09/23 Withdrawn
Clopidogrel ratiopharm Human clopidogrel clopidogrel EMEA/H/C/001173 Archie Samuel s.r.o. 2009/09/23 Withdrawn
Cayston Human aztreonam aztreonam lysine EMEA/H/C/000996 Gilead Sciences Ireland UC 2009/09/21 Authorised
Javlor Human vinflunine vinflunine EMEA/H/C/000983 Pierre Fabre Medicament 2009/09/21 Authorised
Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Human clopidogrel clopidogrel hydrochloride EMEA/H/C/001134 Taw Pharma (Ireland) Limited 2009/09/21 Authorised

数据库说明：

©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase